Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy

Outcome of 11 children with ependymoblastoma treated within the prospective HIT-trials between 1991 and 2006

(2011) Nicolas U. Gerber et al.   JOURNAL OF NEURO-ONCOLOGY

Treatment of young children with localized medulloblastoma by chemotherapy alone: Results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology

(2011) A. O. von Bueren et al.   NEURO-ONCOLOGY

Focal genomic amplification at 19q13.42 comprises a powerful diagnostic marker for embryonal tumors with ependymoblastic rosettes

(2010) Andrey Korshunov et al.   ACTA NEUROPATHOLOGICA

Non-cerebellar primitive neuroectodermal tumors (PNET): Summary of the Milan consensus and state of the art workshop on marrow ablative chemotherapy with hematopoietic cell rescue for malignant brain tumors of childhood and adolescents

(2010) Jason Fangusaro et al.   PEDIATRIC BLOOD & CANCER

Neuropsychological functioning of children treated with intensive chemotherapy followed by myeloablative consolidation chemotherapy and autologous hematopoietic cell rescue for newly diagnosed CNS tumors: An analysis of the Head Start II survivors

(2010) Stephen A. Sands et al.   PEDIATRIC BLOOD & CANCER

Neuroradiologic Review in Pediatric Brain Tumor Studies

(2009) Monika Warmuth-Metz et al.   CLINICAL NEURORADIOLOGY

Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy

(2009) Stefan Rutkowski et al.   NEURO-ONCOLOGY

Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): Report of the Head Start I and II experience

(2007) Jason Fangusaro et al.   PEDIATRIC BLOOD & CANCER